[Prostaglandin E in acute viral hepatitis]

Area of Science:

• Hepatology
• Immunology
• Biochemistry

Background:

• Viral hepatitis, particularly hepatitis B (VHB), poses a significant global health challenge.
• Prostaglandins, including Prostaglandin E (PGE), are bioactive lipids with diverse physiological roles, including immune modulation.
• Altered PGE levels have been implicated in various inflammatory and infectious diseases.

Purpose of the Study:

• To investigate and compare Prostaglandin E levels in patients with acute viral hepatitis B (VHB) and viral hepatitis A (VHA) against healthy controls.
• To explore the relationship between Prostaglandin E levels and Hepatitis B surface antigen (HBsAg) concentration in VHB patients.

Main Methods:

• Blood samples were collected from 47 VHB patients, 17 VHA patients, and 15 healthy donors.
• Prostaglandin E levels were quantified using radioimmunoassay.
• Hepatitis B surface antigen (HBsAg) concentrations were determined in VHB patients' serum via radioimmunoassay.

Main Results:

• Prostaglandin E levels were significantly decreased in VHB patients compared to healthy donors (p < 0.05).
• A non-significant decrease in Prostaglandin E levels was observed in VHA patients compared to healthy donors.
• An inverse relationship was identified between Prostaglandin E levels and HBsAg concentrations in VHB patients.

Conclusions:

• Acute viral hepatitis B is associated with significantly reduced systemic Prostaglandin E levels.
• The findings suggest a potential role for Prostaglandin E dysregulation in the pathogenesis of viral hepatitis B.
• Further research is warranted to elucidate the immunomodulatory functions of Prostaglandin E in hepatitis B infection.